As complementaryDNA add-back experiments are complicated by the large size of ATM (350 kDa) and poor transfectability of the lung cancer cell lines, we next employed RNA-guided nucleases (RGNs)22 as an alternative approach to inactivate ATM and confirm the synthetic lethal interaction. The gene discussed is ATM; the disease is lung carcinoma.